Unlike the novel mRNA technology used in other leading vaccines, CoronaVac employs a well-established inactivated virus method .
CoronaVac, developed by the Chinese biopharmaceutical company Sinovac Biotech , represents one of the most widely utilized tools in the global response to the SARS-CoV-2 pandemic. As a traditional whole-cell inactivated vaccine, it has played a critical role in providing accessible immunization, particularly in low- and middle-income countries. Mechanism of Action: The Traditional Inactivated Approach Coronavac.zip
CoronaVac's efficacy has been the subject of diverse clinical findings, often varying by region and circulating variants: Unlike the novel mRNA technology used in other
of inactivated SARS-CoV-2 virus with aluminum hydroxide as an adjuvant to enhance the immune response. Efficacy and Real-World Effectiveness Coronavac.zip